Clinical Trial News and Research

RSS
Reata, Abbott partner to develop and commercialize AIMs for chronic diseases

Reata, Abbott partner to develop and commercialize AIMs for chronic diseases

Research assesses safety and efficacy of pre-operative transfusions, hydroxyurea therapy for SCD

Research assesses safety and efficacy of pre-operative transfusions, hydroxyurea therapy for SCD

Research examines novel treatment techniques for hemophilia B, VTE

Research examines novel treatment techniques for hemophilia B, VTE

ICON agrees to acquire BeijingWits

ICON agrees to acquire BeijingWits

Re-treatment with rituximab may benefit patients with LTB follicular lymphoma

Re-treatment with rituximab may benefit patients with LTB follicular lymphoma

PCI-32765 is highly active and well tolerated in patients with CLL

PCI-32765 is highly active and well tolerated in patients with CLL

New research on diagnosis and treatment of leukemia to be presented at 53rd ASH meeting

New research on diagnosis and treatment of leukemia to be presented at 53rd ASH meeting

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

Obese women with early-stage HER2-positive breast cancer may have poorer outcomes

Obese women with early-stage HER2-positive breast cancer may have poorer outcomes

PCI-32765 produces durable remissions in Phase I/II CLL clinical trial

PCI-32765 produces durable remissions in Phase I/II CLL clinical trial

New data from TetraLogic's TL32711 study on AML presented at 53rd ASH meeting

New data from TetraLogic's TL32711 study on AML presented at 53rd ASH meeting

ACE inhibitors, ARBs have different effects on heart health of dialysis patients

ACE inhibitors, ARBs have different effects on heart health of dialysis patients

Gene therapy can reduce painful bleeding episodes in patients with hemophilia B

Gene therapy can reduce painful bleeding episodes in patients with hemophilia B

Study describes miR-124 can prevent and treat liver cancer

Study describes miR-124 can prevent and treat liver cancer

Memgen to present ISF35 clinical trial data on CLL at 53rd ASH meeting

Memgen to present ISF35 clinical trial data on CLL at 53rd ASH meeting

Breast cancer hope with new drug and new combination regimens

Breast cancer hope with new drug and new combination regimens

Abbott commences Absorb-XIENCE PRIME comparative clinical trial

Abbott commences Absorb-XIENCE PRIME comparative clinical trial

Positive results from Puma's neratinib Phase II trials presented at CTRC-AACR San Antonio Breast Cancer Symposium

Positive results from Puma's neratinib Phase II trials presented at CTRC-AACR San Antonio Breast Cancer Symposium

Initial results from whole-genome sequencing trial for triple negative breast cancer

Initial results from whole-genome sequencing trial for triple negative breast cancer

Enrollment complete in Boehringer Ingelheim's BI 201335 Phase III trial for HCV

Enrollment complete in Boehringer Ingelheim's BI 201335 Phase III trial for HCV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.